Control of pelvic symptoms in patients with rectal cancer and synchronous metastases

Gastroenterologie Clinique et Biologique

Volumn 33, Issue 12, 2009, Pages 1106-1113

  Tougeron, D ^a   Di Fiore, F ^a   Lefebure, B ^b   Hamidou, H ^c   Tuech, J J ^b   Michot, F ^b   Paillot, B ^a   Michel, P ^a  

^a Digestive Oncology Unit   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c CRLCC Becquerel   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COLOSTOMY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GASTROINTESTINAL OBSTRUCTION; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT SELECTION; PELVIS PAIN SYNDROME; RECTUM CANCER; RECTUM HEMORRHAGE; RECTUM RESECTION; SURVIVAL TIME; TENESMUS;

AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PELVIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 71249084364     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.02.040     Document Type: Article

References (21)

1. Mella J., Biffin A., Radcliffe A.G., Stamatakis J.D., and Steele R.J. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg 84 (1997) 1731-1736
2. Leporrier J., Maurel J., Chiche L., Bara S., Segol P., and Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93 (2006) 465-474
3. O'Neil B.H., and Tepper J.E. Current options for the management of rectal cancer. Curr Treat Options Oncol 8 (2007) 331-338
4. Pasetto L.M., Rossi E., Paris M.K., Lonardi S., and Monfardini S. Common management of primary rectal carcinoma in patients with stage IV disease at the diagnosis. Anticancer Res 23 (2003) 4999-5004
5. Cook A.D., Single R., and McCahill L.E. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol 12 (2005) 637-645
6. Chu Q.D., Davidson R.S., Rodriguez-Bigas M.A., Wirtzfeld D.A., and Petrelli N.J. Is abdominoperineal resection a good option for stage IV adenocarcinoma of the distal rectum?. J Surg Oncol 81 (2002) 3-7
7. Nash G.M., Saltz L.B., Kemeny N.E., Minsky B., Sharma S., Schwartz G.K., et al. Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol 9 (2002) 954-960
8. Crane C.H., Janjan N.A., Abbruzzese J.L., Curley S., Vauthey J., Sawaf H.B., et al. Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. Int J Radiat Oncol Biol Phys 49 (2001) 107-116
9. Tekkis P.P., Poloniecki J.D., Thompson M.R., and Stamatakis J.D. Operative mortality in colorectal cancer: prospective national study. BMJ 327 (2003) 1196-1201
10. Kohne C.H., Cunningham D., Di C.F., Glimelius B., Blijham G., Aranda E., et al. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol 13 (2002) 308-317
11. Makela J., Haukipuro K., Laitinen S., and Kairaluoma M.I. Palliative operations for colorectal cancer. Dis Colon Rectum 33 (1990) 846-850
12. Fitzgerald S.D., Longo W.E., Daniel G.L., and Vernava III A.M. Advanced colorectal neoplasia in the high-risk elderly patient: is surgical resection justified?. Dis Colon Rectum 36 (1993) 161-166
13. Kuo L.J., Leu S.Y., Liu M.C., Jian J.J., Hongiun C.S., and Chen C.M. How aggressive should we be in patients with stage IV colorectal cancer?. Dis Colon Rectum 46 (2003) 1646-1652
14. Scheer M.G., Sloots C.E., van der Wilt G.J., and Ruers T.J. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 19 (2008) 1829-1835
15. Esnaola N.F., Cantor S.B., Johnson M.L., Mirza A.N., Miller A.R., Curley S.A., et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 20 (2002) 4361-4367
16. Guyot F., Faivre J., Manfredi S., Meny B., Bonithon-Kopp C., and Bouvier A.M. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol 16 (2005) 756-761
17. Grothey A., Sargent D., Goldberg R.M., and Schmoll H.J. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22 (2004) 1209-1214
18. Michel P., Roque I., Di Fiore F., Langlois S., Scotte M., Teniere P., et al. Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected?. Gastroenterol Clin Biol 28 (2004) 434-437
19. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336 (1997) 980-987
20. Habeshaw T., Adam J.S., and Kirk J. Weekly large fraction radiotherapy and 5 fluorouracil as a palliative treatment for large bowel carcinoma: a pilot study. Int J Radiat Oncol Biol Phys 8 (1982) 1127-1130
21. Benoist S., Pautrat K., Mitry E., Rougier P., Penna C., and Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 92 (2005) 1155-1160